Literature DB >> 33925451

Cytokine, Chemokine, and Metalloprotease Activation in the Serum of Patients with Nephropathia Epidemica from the Republic of Tatarstan and the Republic of Mordovia, Russia.

Ekaterina Martynova1, Yuriy Davidyuk1, Emmanuel Kabwe1, Ekaterina E Garanina1, Venera Shakirova2, Vera Pavelkina3, Yulia Uskova3, Robert J Stott4, Toshana L Foster4, Maria Markelova1, Mehendi Goyal5, Abhimat Gupta6, Mannan Bhola7, Vinay Kumar8, Manoj Baranwal7, Albert A Rizvanov1, Svetlana F Khaiboullina1.   

Abstract

Nephropathia Epidemica (NE), endemic to several Volga regions of Russia, including the Republic of Tatarstan (RT) and the Republic of Mordovia (RM), is a mild form of hemorrhagic fever with renal syndrome caused by infection with rodent-borne orthohantaviruses. Although NE cases have been reported for decades, little is known about the hantavirus strains associated with human infection in these regions. There is also limited understanding of the pathogenesis of NE in the RT and the RM. To address these knowledge gaps, we conducted comparative analyses of patients with NE in the RT and the RM. Clinical symptoms were more severe in patients with NE from the RM with longer observed duration of fever symptoms and hospitalization. Analysis of patient sera showed changes in the levels of numerous cytokines, chemokines, and matrix metalloproteases (MMPs) in patients with NE from both the RT and the RM, suggesting leukocyte activation, extracellular matrix degradation, and leukocyte chemotaxis. Interestingly, levels of several cytokines were distinctly different between patients NE from the RT when compared with those from the RM. These differences were not related to the genetic variation of orthohantaviruses circulating in those regions, as sequence analysis showed that Puumala virus (PUUV) was the causative agent of NE in these regions. Additionally, only the "Russia" (RUS) genetic lineage of PUUV was detected in the serum samples of patients with NE from both the RT and the RM. We therefore conclude that differences in serum cytokine, chemokine, and MMP levels between the RT and the RM are related to environmental factors and lifestyle differences that influence individual immune responses to orthohantavirus infection.

Entities:  

Keywords:  Nephropathia Epidemica; chemokine; cytokine; metalloprotease

Year:  2021        PMID: 33925451     DOI: 10.3390/pathogens10050527

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  68 in total

1.  IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation.

Authors:  Peleg Rider; Yaron Carmi; Ofer Guttman; Alex Braiman; Idan Cohen; Elena Voronov; Malka R White; Charles A Dinarello; Ron N Apte
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

2.  IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells.

Authors:  K Tominaga; T Yoshimoto; K Torigoe; M Kurimoto; K Matsui; T Hada; H Okamura; K Nakanishi
Journal:  Int Immunol       Date:  2000-02       Impact factor: 4.823

3.  IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.

Authors:  M Magdalena Gherardi; Juan C Ramírez; Mariano Esteban
Journal:  J Gen Virol       Date:  2003-08       Impact factor: 3.891

4.  Innate immune cells contribute to the IFN-gamma-dependent regulation of antigen-specific CD8+ T cell homeostasis.

Authors:  Ozen Sercan; Günter J Hämmerling; Bernd Arnold; Thomas Schüler
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 5.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 6.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases.

Authors:  Brett D Shepard; Andrew D Badley
Journal:  Antiinfect Agents Med Chem       Date:  2009-04-01

8.  Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus.

Authors:  Marika Hjertqvist; Sabra L Klein; Clas Ahlm; Jonas Klingstrom
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883

Review 9.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

10.  Flash-Like Albuminuria in Acute Kidney Injury Caused by Puumala Hantavirus Infection.

Authors:  Paula Mantula; Johanna Tietäväinen; Jan Clement; Onni Niemelä; Ilkka Pörsti; Antti Vaheri; Jukka Mustonen; Satu Mäkelä; Tuula Outinen
Journal:  Pathogens       Date:  2020-07-28
View more
  2 in total

1.  Cells of the human respiratory tract support the replication of pathogenic Old World orthohantavirus Puumala.

Authors:  Stefan Hägele; Christian Nusshag; Alexander Müller; Alexandra Baumann; Martin Zeier; Ellen Krautkrämer
Journal:  Virol J       Date:  2021-08-17       Impact factor: 4.099

2.  Serum Markers Associated with Disease Severity in a Bosnian Hemorrhagic Fever with Renal Syndrome Cohort.

Authors:  Danny Noack; Maja Travar; Visnja Mrdjen; Jolanda J C Voermans; David van de Vijver; Richard Molenkamp; Marion P G Koopmans; Marco Goeijenbier; Barry Rockx
Journal:  Viruses       Date:  2022-06-24       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.